The European Commission for the Control of Foot-and-Mouth Disease (EuFMD)

Research Group of the Standing Technical Committee 'Open Session' 2018

29/10/2018 - 31/10/2018
Borgo Egnazia (Puglia), Italy,

 

The Open Session of the EuFMD Standing Technical Committee was held in Borgo Egnazia, Italy on 29-31 October 2018

 

Appendix 1: Meeting Agenda  

Appendix 2: List of Participants   

Appendix 3: Poster Presentations   

Appendix 4: Global Status Report for FMD: Tracking the Emergence and Spread of New Viral Lineages  

Appendix 5: Modelling FMD Vaccine Requirements for Multi-Country FMD Outbreaks in Europe    

Appendix 6: Evaluating Vaccination Strategies to Control FMD: A Country Comparison Study     

Appendix 7: Understanding Vaccine Demand in the Endemic Setting       

Appendix 8: Household Perceptions of Risk As Drivers for Adoption of FMD Vaccination

Appendix 9: Mass FMD Vaccination in Central Myanmar, 2015-2016

Appendix 10: Assessment of the Risk of Incursion Of Exotic FMD Viruses into Southeast Asia

Appendix 11: Vaccine Banks: Policy Options Evaluated Using the EU Evaluation Framework

Appendix 12: The Challenges of FMD Vaccine Production

Appendix 13: Mutual Registration of Vaccines in East Africa: Progress and Issues for Better Access to Effective FMD Vaccines?

Appendix 14: Identification of Genes Involved in Pathogenicity of FMD Virus Using Two Strains Isolated in Japan with Different Viral Features

Appendix 15: Complete Genome Sequence Analysis of over 140 FMD Viruses Isolated from Free-Living African Buffalo (Syncerus Caffer) in Zimbabwe 

Appendix 16: Evolution and Competition of Sat Strains During Buffalo Transmission in a Controlled Challenge Experiment

Appendix 17: FMDV Evolutionary Dynamics within Infected Buffaloes and Its Large-Scale Consequences 

Appendix 18: Antibody Responses to the Major Antigenic Sites of FMD Virus Serotype O After Primo-Vaccination, Re-Vaccination and After Natural Exposure   

Appendix 19: Exploring Private and Public Sector Rights and Responsibilities in Prevention and Control of FMD: The Case of Right to Access Vaccines by Livestock Keepers

Appendix 20: FMD Research Gap Analysis Workshop 2018 

Appendix 21: Gene Signatures Associated with FMDV Infection and Persistence Part I: Persistent FMDV Infection in An Air-Liquid Interface Model Of Bovine Soft Palate 

Appendix 22: Gene Signatures Associated with FMDV Infection and Persistence Part II   

Appendix 23: Transmision of Fmd from Persistently Infected Carrier Cattle to NaïVe Cattle via Transfer of Oropharyngeal Fluid

Appendix 24: Rapid, On Site, Diagnosis of FMD and Safe and Cost-Effective Shipment of Samples Using Lateral Flow Devices for Laboratory Diagnostics

Appendix 25: The Utility of Pooled Milk for Fmd Surveillance in Nakuru County, Kenya

Appendix 26: Evaluation of Environmental Sampling As a Low Technology Method for Surveillance of FMDV in an Endemic Area

Appendix 27: Environmental Sampling: A Surveillance Tool for FMDV in Marketplaces

Appendix 28: Effective in Silico Sequence-Based Prediction of FMDV Vaccine Matching

Appendix 29: In-Vitro Correlates of Heterologous Protection Using Avidity and Igg-Subtyping Elisas

Appendix 30: Assessment of Existing and Future Vaccine Selection Techniques –Moving Forward

Appendix 31: Reinforcement Learning for Context-Dependent Control of Emergency Outbreaks of FMD

Appendix 32: Investigating The Benefits of an Adaptive Management Approach Involving Emergency Vaccination Using Simulated FMD Outbreaks in New Zealand

Appendix 33: Evaluating Optimal Control Strategies for FMD with the Us Disease Outbreak Simulation

Appendix 34: Between-Herd Transmission Dynamics of FMD in Kenya Rangelands

Appendix 35: Using Networks of Livestock Mobility to Improve Control of Endemic FMD in Northern Tanzania

Appendix 36: Livestock Mobility in West Africa: Network Analysis and Applications

Appendix 37: Qualitative Aspects of the Immune Responses Related to Protection Against FMDV Challenge in Cattle

Appendix 38: Secure Beef Supply in The U.S. Planning for Control and Continuity of Business in an FMD Outbreak

Appendix 39: Modelling the Impact of Regional Movement Control Policies for FMD Outbreaks in Disease Free Countries

Appendix 40: Modelling Management Strategies for Vaccinated Animals After an Outbeak of FMD and the Impact on Return to Trade

Appendix 41: Vaccine Efficacy of FMD Virus-Like Particles Produced by the Baculovirus Expression System

Appendix 42: A Current Perspective on Adenovirus 5-Vectored FMD Vaccines

Appendix 43: FMD-LL3B3D Vaccine Platform: Safe, Highly Potent, Fully Diva Compatible,Inactivated FMDV Vaccines

Appendix 44: An Overview of Reverse Genetic Approaches to Enhanced FMD Vaccines in Africa

Appendix 45: Rational Design of Attenuated FMDV Vaccines by Elevation of –Cpg- And –Upa- Dinucleotide Frequencies

Appendix 46: Field Trial to Estimate the Effectiveness of the Vaccination Program Implemented in the Maghreb Region

Appendix 47: Modelling the Impact of Farming Practices upon Vaccine Effectiveness in Endemic Settings – A Case Study in Kenya

Appendix 48: Genetic Characterization of FMDV Responsible for Outbreaks in Nigeria During 2016:Resurgence of the Novel Fmd- Sat1 Topotype

Appendix 49: Serological and Molecular Epidemiology of FMD Viruses in Agro-Pastoralist Livestock Herds in the Kachia Grazing Reserve, Nigeria

Appendix 50: Complex Concomitance of FMDV Strains in Nigeria

Appendix 51: Foot-And-Mouth Disease in Small Ruminants and in Wildlife In Northern Nigeria

Appendix 52: Serotyping Seroprevalence of FMD in Cattle from Uganda Surveillance 2014-2018

Appendix 53: Foot-And-Mouth Disease in Burundi

Appendix 54: Does the African Buffalo Really Spread FMD? A Sero-Survey of FMD in Cattle Around Mana Pools Conservation Park of Northern Zimbabwe

Appendix 55: Control Methods of FMD in Benin by Trial Vaccination and Medicinal Plants

Appendix 56: Molecular Characterisation of FMDV Detected During 2015 - 2018 in Tanzania:Insights for Virus Diversity and Evolution In Africa

Appendix 57: FMD Surveillance and Control in Mali

Appendix 58: A Gvii-2015, A New High Potency Vaccine With Broad Protection Against A/Asia/G-Vii Threat

Appendix 59: Intradermal Application of FMD Vaccines for Pigs

Appendix 60: Efficacy of A/MAY/97 FMDV Vaccine Against Heterologous Challenge With a Field Virus from the Emerging A/ASIA/G-VII Lineage in Cattle

Appendix 61: A Simple Universal Test to Quantitate 146s Antigen During Production of FMD Vaccines

Appendix 62: Improving the Duration of Immunity for FMD Vaccines

Appendix 63: The Use of Reverse Genetics to Facilitate the Growth of FMDV for the Production of Vaccines

Appendix 64: Multiplex Real-Time Rt-Pcr for Detection Of Fmdv, Rift Valley Fever Virus and Bovine Viral Diarrhea Virus in Bulk Tank Milk

Appendix 65: Emergency Supply of Fmd Diagnostic Kits: Reagent Banks and Idvet Solutions

Appendix 66: Results From an Inter-Laboratory Exercise to Evaluate Non-Structural Protein Elisa Kits

Appendix 67: Results of the 2016 and 2017 Proficiency Testing Schemes for FMD Diagnostic Methods

Appendix 68: The Interdependence of FMDV Pathogenesis, Challenge System, and Outcome of Vaccine Studies

Appendix 69: Good Correlation Between Vaccine Match in Potency Tests and R1-Value

Appendix 70: Potency Assessment of FMD Vaccines Using Standardised Serological Assays

Appendix 71: Detection of FMFV O/ME-SA/IND-2001E in Jordan

Appendix 72: The Association Between Border Provinces of Turkey and FMD Outbreaks

Appendix 73: Integrated Risk-Based Strategic Plans for Five Priority Diseases in the Palestinian Authority

Appendix 74: Embedding Progressive Control for FMD in the Policy Agenda For Livestock Production in Three Countries in Southeast Asia

Appendix 75: Trans-Pool Movement of Two FMD Virus Serotype A Lineages:A/ASIA/G-VII and A/AFRICA/G-IV

Appendix 76: Socio-Economic Impact of FMD Outbreaks And Control Measures At Different Scales in Mongolia: From National Level Gross Losses To Herders’ Food Security

Appendix 77: Retrospective FMD Outbreak Reports From Uganda and Tanzania Border Districts (2011-2016): Implications for FMD Control by Vaccination

Appendix 78: Update of FMD in the Maghreb Region: Vaccination Issues

Appendix 79: Assessment of FMD Vaccines in Mongolia and the Role of Bactrian Camels

Appendix 80: Mobile Application Results